Have a personal or library account? Click to login
Protective effects of resveratrol against fumonisin B1-induced liver toxicity in mice Cover

Protective effects of resveratrol against fumonisin B1-induced liver toxicity in mice

Open Access
|Jun 2023

References

  1. Alshannaq A, Yu JH. Occurrence, toxicity, and analysis of major mycotoxins in food. Int J Environ Res Public Health 2017;14:632. doi: 10.3390/ijerph14060632
  2. Bhat R, Rai RV, Karim AA. Mycotoxins in food and feed: present status and future concerns. Compr Rev Food Sci Food Saf 2010;9:57–81. doi: 10.1111/j.1541-4337.2009.00094.x
  3. Gelderblom WC, Jaskiewicz K, Marasas WF, Thiel PG, Horak RM, Vleggaar R, Kriek NP. Fumonisins-novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl Environ Microbiol 1988;54:1806–11. doi: 10.1128/aem.54.7.1806-1811.1988
  4. Vidal A, Mengelers M, Yang S, De Saeger S, De Boevre M. Mycotoxin biomarkers of exposure: a comprehensive review. Compr Rev Food Sci Saf 2018;17:1127–55. doi: 10.1111/1541-4337.12367
  5. International Agency for Research on Cancer (IARC). Fumonisin B1. In: IARC monographs on the evaluation of carcinogenic risks to humans, No. 82. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. Lyon: IARC; 2002. p. 301–66.
  6. Marasas WFO, Wehner FC, Van Rensburg SJ, Van Schalkwyk DJ. Mycoflora of corn produced in human esophageal cancer areas in Transkei, Southern Africa. Phytopathology 1981;71:792–6. doi: 10.1094/phyto-71-792
  7. Sun G, Wang S, Hu XS, Su J, Huang T, Yu J, Tang L, Gao W, Wang J. Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China. Food Addit Contam 2007;24:181–5. doi: 10.1080/02652030601013471
  8. Marasas WF, Kellerman TS, Gelderblom WC, Coetzer JA, Thiel PG, Lugt JJ. Leukoencephalomalacia in a horse induced by fumonisin B1 isolated from Fusarium moniliforme. Onderstepoort J Vet Res 1988;55:197–203. PMID: 3217091
  9. Smith GW, Constable PD, Eppley RM, Tumbleson ME, Gumprecht LA, Haschek-Hock WM. Purified fumonisin B1 decreases cardiovascular function but does not alter pulmonary capillary permeability in swine. Toxicol Sci 2000;56:240–9. doi: 10.1093/toxsci/56.1.240
  10. Voss KA, Plattner RD, Riley RT, Meredith FI, Norred WP. In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: Fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats. Mycopathologia 1998;141:45–58. doi: 10.1023/a:1006810916344
  11. He Q, Suzuki H, Sharma N, Sharma RP. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver. Toxicol Sci 2006;94:388–97. doi: 10.1093/toxsci/kfl102
  12. Ferrante MC, Meli R, Raso GM, Esposito E, Severino L, Carlo GD, Lucisano A. Effect of fumonisin B1 on structure and function of macrophage plasma membrane. Toxicol Lett 2002;129:181–7. doi: 10.1016/S0378-4274(01)00476-3
  13. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012;24:981–90. doi: 10.1016/j.cellsig.2012.01.008
  14. Kunwar A, Priyadarsini KI. Free radicals, oxidative stress and importance of antioxidants in human health. J Med Allied Sci 2011;1(2):53–60.
  15. Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR. Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem 2004;52:4713–9. doi: 10.1021/jf040095e
  16. Roat C, Saraf M. [Vıtıs vınıfera’dan bir endofıtik mantar aspergıllus stellıfer ab4’ün biyoaktif bir ikinci metaboliti olan t-resveratrol ve α-vınıferın’in izolasyonu ve karakterizasyonu, in Turkey]. Mikrobiyoloji, Biyoteknoloji ve Gıda Bilimleri Dergisi 2021;708–13.
  17. Kuršvietienė L, Stanevičienė I, Mongirdienė A, Bernatoniene J. Multiplicity of effects and health benefits of resveratrol. Medicina (Kaunas)2016;52:148–55. doi: 10.1016/j.medici.2016.03.003
  18. Cigremis Y, Akgoz M, Ozen H, Karaman M, Kart A, Gecer M, Atalan G. Resveratrol ameliorates cisplatin-induced oxidative injury in New Zealand rabbits. Can J Physiol Pharmacol 2015;93:727–35. doi: 10.1139/cjpp-2014-0420
  19. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277–85. doi: 10.1016/j.clinbiochem.2003.11.015
  20. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–11. doi: 10.1016/j.clinbiochem.2005.08.008
  21. Kongtawelert P, Tangkijvanich P, Ong-Chai S, Poovorawan Y. Role of serum total sialic acid in differentiating cholangiocarcinoma from hepatocellular carcinoma. World J Gastroenterol 2003;9:2178–81. doi: 10.3748/wjg.v9.i10.2178
  22. Arif S, Najeeb-ul-Haq, Hanif R, Khan AS, Jamil-ur-Rehman, Mufti TA. Variations of serum sialic acid level in liver cirrhosis. J Ayub Med Coll Abbottabad 2005;17:54–7. PMID: 16320799
  23. Sydow G. A simplified quick method for determination of sialic acid in serum. Biomed Biochim Acta 1985;44:1721–3. PMID: 3004424
  24. He Q, Kim J, Sharma RP. Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases. Toxicol Sci 2004;80:335–42. doi: 10.1093/toxsci/kfh148
  25. Sharma N, He Q, Sharma RP. Amelioration of fumonisin B1 hepatotoxicity in mice by depletion of T cells with anti-Thy-1.2. Toxicology 2006;223:191–201. doi: 10.1016/j.tox.2006.03.021
  26. Krupashree K, Rachitha P, Jayashree GV, Khanum F. Protective effects of Picrorhizakurroa against fumonisin B1 induced hepatotoxicity in mice. Int J Cur Res Rev 2018;10:25–31. doi: 10.31782/IJCRR.2018.10206
  27. Şehirli O, Tozan A, Omurtag, GZ, Çetinel S, Contuk G, Gedik N, Şener G. Protective effect of resveratrol against naphthalene-induced oxidative stress in mice. Ecotoxicol Environ Saf 2008;71:301–8. doi: 10.1016/j.ecoenv.2007.08.023
  28. Atmaca N, Atmaca HT, Kanici A, Anteplioglu T. Protective effect of resveratrol on sodium fluoride-induced oxidative stress, hepatotoxicity and neurotoxicity in rats. Food Chem Toxicol 2014;70:191–7. doi: 10.1016/j.fct.2014.05.011
  29. Zhou Y, Jin Y, Yu H, Shan A, Shen J, Zhou C, Zhao Y, Fang H, Wang X, Wang J, Fu Y, Wang R, Li R, Zhang J. Resveratrol inhibits aflatoxin B1-induced oxidative stress and apoptosis in bovine mammary epithelial cells and is involved the Nrf2 signaling pathway. Toxicon 2019;164:10–5. doi: 10.1016/j.toxicon.2019.03.022
  30. Rašić D, Mladinić M, Želježić D, Pizent A, Stefanović S, Milićević D, Peraica M. Effects of combined treatment with ochratoxin A and citrinin on oxidative damage in kidneys and liver of rats. Toxicon 2018;146:99–105. doi: 10.1016/j.toxicon.2018.03.002
  31. Shaito A, Posadino AM, Younes N, Hasan H, Halabi S, Alhababi D, Al-Mohannadi A, Abdel-Rahman WM, Eid AH, Nasrallah GK, Pintus G. Potential adverse effects of resveratrol: A literature review. Int J Mol Sci 2020;21(6):2084. doi: 10.3390/ijms21062084
  32. Karaica D, Micek V, Rašić D, Peraica M, Šegvić Klarić M, Breljak D. Subchronic exposure to individual and combined ochratoxin A and citrinin affects the expression of rat renal organic anion transporters. Mycotoxin Res 2020;36:339–52. doi: 10.1007/s12550-020-00399-4
  33. Ali SA, Faddah L, Abdel-Baky A, Bayoumi A. Protective effect of L-carnitine and coenzyme Q10 on CCl4-induced liver injury in rats. Sci Pharm 2010;78:881–96. doi: 10.3797/scipharm.1006-02
  34. Cemek M, Aymelek F, Büyükokuroğlu ME, Karaca T, Büyükben A, Yilmaz F. Protective potential of Royal Jelly against carbon tetrachloride induced-toxicity and changes in the serum sialic acid levels. Food Chem Toxicol 2010;48:2827–32. doi: 10.1016/j.fct.2010.07.013
  35. Yapar K, Kart A, Karapehlivan M, Atakisi O, Tunca R, Erginsoy S, Citil M. Hepatoprotective effect of L-carnitine against acute acetaminophen toxicity in mice. Exp Toxicol Pathol 2007;59:121–8. doi: 10.1016/j.etp.2007.02.009
DOI: https://doi.org/10.2478/aiht-2023-74-3648 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 115 - 119
Submitted on: Apr 1, 2022
Accepted on: May 1, 2023
Published on: Jun 26, 2023
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2023 Rıza Yalçın, Asım Kart, Özlem Özmen, Esra Zeybek, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.